Latest Disc Medicine News & Updates

See the latest news and media coverage for Disc Medicine. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Disc Medicine

Biopharmaceutical company developing hematology treatments

discmedicine.com
Headquarters
Watertown, United States
Company type
Public company
Number of employees
150–200
Industry
Pharmaceuticals

Last updated

Latest news about Disc Medicine

In short: Disc Medicine aligned with the FDA on a path for bitopertin after a rejection and reported positive Phase 2 data across its clinical pipeline.

Company announcements

Disc Medicine

Disc Medicine reports Q1 2026 financial results

Cash at $730M funds into 2029. Completed Phase 3 enrollment for bitopertin in EPP; data expected Q4 2026. Updates on DISC-0974 and DISC-3405 trials.

Unlock all announcements with a

Media coverage

Yahoo Finance

Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update

Completed Type A meeting with the FDA on bitopertin and aligned that the Phase 3 APOLLO study, if successful, can serve as the basis for...

Unlock all articles with a

Never miss news about Disc Medicine

Track Disc Medicine and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Disc Medicine competitors & trending companies

Browse news for competitors to Disc Medicine and other trending companies.